Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 19 Breast Neoplasms 18 Leukemia, Myeloid, Acute 9 Ovarian Neoplasms 6 Lymphoma 6 Hematologic Neoplasms 6 Glioblastoma 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Lung Neoplasms 5 Stomach Neoplasms 4 Leukemia 4 Fatigue 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Myelodysplastic Syndromes 3 Motor Activity 3 Depression 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Pain 2

Interventions

lutetium Lu 177 dotatate 29 Everolimus 19 Temozolomide 11 gallium Ga 68 dotatate 10 Nivolumab 10 Magnetic Resonance Spectroscopy 10 Capecitabine 9 pembrolizumab 8 lanreotide 8 Positron Emission Tomography Computed Tomography 8 cabozantinib 7 3-Iodobenzylguanidine 7 177Lu-octreotide, DOTA(0)-Tyr(3)- 7 Somatostatin 6 90Y-octreotide, DOTA-Tyr(3)- 6 telotristat ethyl 5 lenvatinib 5 Octreotide 5 Lutetium-177 5 Ga(III)-DOTATOC 5 Fluorodeoxyglucose F18 5 Carboplatin 5 avelumab 4 Positron-Emission Tomography 4 Ipilimumab 4 Bevacizumab 4 surufatinib 3 pasireotide 3 fluorodopa F 18 3 copper dotatate CU-64 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroendocrine Tumors × Palliative Care × Clear all

NCT01849523 2024-05-06

WIN

University Medical Center Groningen

Phase NA Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡